PREDICTING SYSTEMIC EXPOSURE IN HUMANS FOR A NOVEL DRUG WITH LOW ORAL BIOAVAILABILITY AND LOCAL ACTION IN THE GUT.

46

  • Schmith, V. D.
  • Zuo, P.
  • Padovan, J.
  • Stephens, K.
  • Kulkarni, S.
  • Oreskovic, K.

  • GlaxoSmithKline 1Research Triangle Park, NC, US; 2Research Centre Zagreb, Croatia; 3Stevenage, UK; 3Ware, UK

The Journal of Clinical Pharmacology 50(9):p 1067, September 2010.
Copyright © 2010 American College of Clinical Pharmacology
View full text|Download PDF